Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · IEX Real-Time Price · USD
2.300
+0.100 (4.55%)
At close: May 17, 2024, 2:21 PM
2.170
-0.130 (-5.65%)
After-hours: May 17, 2024, 4:00 PM EDT
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $59.64 million as of May 17, 2024. Its market cap has increased by 0.07% in one year.
Market Cap
59.64M
Enterprise Value
54.50M
1-Year Change
0.07%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $59.64M, a decrease of -63.38%. That is a compound annual growth rate of -28.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 59.60M | 4.01% |
May 16, 2024 | 57.30M | -6.37% |
May 15, 2024 | 61.20M | 3.55% |
May 14, 2024 | 59.10M | -5.44% |
May 13, 2024 | 62.50M | -19.97% |
May 10, 2024 | 78.10M | 0.39% |
May 9, 2024 | 77.80M | -1.27% |
May 8, 2024 | 78.80M | - |
May 7, 2024 | 78.80M | 3.01% |
May 6, 2024 | 76.50M | - |
May 3, 2024 | 76.50M | -5.44% |
May 2, 2024 | 80.90M | 5.34% |
May 1, 2024 | 76.80M | 2.13% |
Apr 30, 2024 | 75.20M | 5.47% |
Apr 29, 2024 | 71.30M | 1.71% |
Apr 26, 2024 | 70.10M | -3.31% |
Apr 25, 2024 | 72.50M | 0.14% |
Apr 24, 2024 | 72.40M | 2.99% |
Apr 23, 2024 | 70.30M | 1.15% |
Apr 22, 2024 | 69.50M | -3.61% |
Apr 19, 2024 | 72.10M | -2.44% |
Apr 18, 2024 | 73.90M | -5.01% |
Apr 17, 2024 | 77.80M | 1.30% |
Apr 16, 2024 | 76.80M | 0.13% |
Apr 15, 2024 | 76.70M | 1.86% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Beyond Air | 62.01M |
Envoy Medical | 61.54M |
Kronos Bio | 61.30M |
Ocean Biomedical | 60.64M |
Genenta Science | 60.12M |
AEON Biopharma | 59.09M |
Augmedix | 58.76M |
Theratechnologies | 58.62M |